ArticleTranslational oncology2025

Longitudinal profiling of hormone receptor positive, HER2 negative metastatic breast cancer through droplet digital PCR-based circulating tumor DNA fragmentomics.

Lorenzo Foffano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.